"If the data does not represent you, it may not suit you!" Historically, men have both led and been the subject of the study of #medicine and biology. What promise do precision medicine, biobank, and commitment hold to close the gap for the health of women? 👇 Temple Therapeutics uses validated biobanks of #female-specific tissues and blood, along with #clinical, #genetic, #ethnic, #prognostic, etc. to discover #biomarkers, #targetedtherapy, and advanced, #non-invasive #diagnostics. Follow us at Temple Therapeutics as we pioneer a new era in precision medicine for the health of women #womenhealth #venturecapital #gynecology #cancers #femtech #precisionmedicine #biobank #bioinformatics #endometriosis #ovariancancer #cervicalcancer #endometrialcancer #AACR Ru-fong Joanne Cheng, MD, FACOG Reenita Das Raysa Bousleiman Juan Camilo Arjona Ferreira Elke Bestel Ksenija Pavletic Ariel Belgrave Harris Anna Brailsford Anita Krohn Traaseth Carol Johnson Dr Claudia Pastides Elaine Pringle Schwitter Ghader Jamjoum Ilana Jacqueline Tamara CAIANI Louise Pentland Manal Rifki Najat Khan, PhD Lesley Stolz Kristi Campoe, PhD, RN, CMSRN, CPHQ, sMBA Kristin Stenerson Kristen Slawinski, PhD
Temple Therapeutics
Biotechnology Research
Geleen, - 683 followers
Pioneering a new era in precision medicine for women's health
About us
A clinical-stage biotechnology company pioneering a female-focused precision medicine approach using validated biobanks for the discovery, development, and commercialization of novel therapeutics and companion diagnostics in women's health.
- Website
-
http://www.templerx.com
External link for Temple Therapeutics
- Industry
- Biotechnology Research
- Company size
- 2-10 employees
- Headquarters
- Geleen, -
- Type
- Privately Held
- Founded
- 2015
- Specialties
- ovarian cancer, endometrial cancer, fibrosis, endometriosis, post surgical adhesions, surgery, women's health, fitness, health, lifestyle, precision medicine, Artificial Intelligence, Machine Learning, Biobank, gynecology, reproductive medicine, infertility, cervical cancer, pcos, femtech, life sciences, and healthcare
Locations
-
Primary
Urmonderbaan 22
Geleen, - 6167 RD, NL
Employees at Temple Therapeutics
Updates
-
"Early detection saves lives. Be thankful for your health this holiday season.” Chris Evert. Harnessing the power of #precisionmedicine for #earlydetection...👇 Temple Therapeutics is harnessing the power of #precisionmedicine and validated #biobanks that span diverse ethnicities and #histotypes to revolutionize our understanding of #ovariancancer and other #gynecology #cancers. 👍 2023 #breakthroughs: 1. April-#AACR- Dr. Ghassan Saed Khalil Helou Anna Portela Mestres revealed novel biomarker and therapeutic for ovarian cancer (https://lnkd.in/g44bY47q) (manuscript submitted) 2. Nov. 2023-Peer-reviewed publication Dr. Ghassan Saed ran 80-patient PoC trial demonstrating a compelling biomarker for #earlydetection of Stage 1 & 2 ovarian cancer (https://lnkd.in/gBQNnj6u) The achievements signify a pivotal stride in reshaping #patient #outcomes and propel Temple Therapeutics to the forefront of #ovariancancer, #diagnosis, #earlydetection, and novel targeted #therapeutics. Follow us Temple Therapeutics, comment, share this post, and help us in the pursuit of redefining what is possible for those battling #ovarian and other #gynecological #cancers. Let's meet up #jpm2024. Send me a personal message. Ovarian Cancer Research Alliance World Ovarian Cancer Coalition ESPN Sharsheret: The Jewish Breast & Ovarian Cancer Community Dr. Ghassan Saed Roche Genentech AbbVie AstraZeneca Organon Theramex GSK https://lnkd.in/gbNpJQtC
Tennis great Chris Evert re-diagnosed with cancer | CNN
cnn.com
-
Role of #Precision #Medicine in #Ovarian #Cancer Research? Advancements in #dnasequencing and #genomic profiling have significantly enhanced our ability to discern which individuals will positively respond to specific therapies. Within this landscape, #precisionmedicine plays a pivotal role in uncovering #noveltargets and #biomarkers. Temple Therapeutics is actively engaged in this transformative work, leveraging validated #biobanks that encompass diverse #histotypes. Recent publications from our research highlight promising biomarkers for #earlydetection (Stage I & II) and innovative targets (links provided in the comments below) signifying a crucial step toward reshaping #patient #outcomes and advancing the frontier of #ovariancancer discovery.
-
Temple Therapeutics Validated biobanks/precision medicine leads to #earlydetection #earlystage biomarker for ovarian cancer (https://lnkd.in/gghUkUym coupled with a novel target (presented at #AACR-https://lnkd.in/gJYZwutg) which seems to be agnostic to subtypes may provide another strategy to improve #ovarianpatient #outcomes. #ovariancancer Society for Women's Health Research (SWHR) Ovarian Cancer Research Alliance World Ovarian Cancer Coalition Roche Organon Ferring Pharmaceuticals https://lnkd.in/g-EVjQvd
Stort Tack till Cancerfonden, och Tack alla som skänker gåvor till forskningen och gör detta möjligt! Vårt projekt om äggstockscancer var ett av de 224 som fick anslag från @Cancerfonden! Projektet handlar om Klinisk betydelse av Lemur Tyrosine Kinase 3 (LMTK3) som potentiellt mål för behandling av äggstockscancer och vi hoppas kunna genom vår behandling med LMTK3-specifika antikroppar och peptider inducera celldöd av både cellgiftskänsliga resp. resistenta cancerceller utan att påverka normala celler. #tillsammansmotcancer #cancerfonden
-
#ovariancancer peer reviewed publication announcement! Lack of early-stage screening methods with high specificity, sensitivity, or both significantly contributes to the observed high mortality rates in #ovariancancer. In this report, we highlight mMPO as a potential biomarker for #earlydetection of #ovariancancer, which is critically needed. Temple Therapeutics we are committed to #womenhealth and improving #patient #outcomes. #ovariancancerawareness #earlydetection #ovarian #cancer #womenhealth Ovarian Cancer Research Alliance World Ovarian Cancer Coalition World Economic Forum https://lnkd.in/gghUkUym
Monomeric myeloperoxidase is a specific biomarker for early-stage ovarian cancer
tandfonline.com
-
Temple Therapeutics A clinical-stage biotechnology company pioneering a female-focused precision medicine approach for the discovery, development, and commercialization of novel therapeutics and companion diagnostics in reproductive medicine. We are redefining what is possible in women's health. It is a good start! #ovariancancer #endometriosis #adhesions #surgery #diagnostics #earlydetection #ACOG #ESHRE #ESGE #AAGL https://lnkd.in/gPs37t36
Remarks as Prepared for Delivery by First Lady Jill Biden on a Press Call Announcing White House Initiative on Women’s Health Research | The White House
whitehouse.gov
-
#Adhesions are very common, yet not talked about. Spoken to many patients suffering from it. Bowel obstruction is an important cause of morbidity and mortality, accounting for nearly 30,000 deaths and more than $3 billion per year in direct medical costs. Temple Therapeutics June 05, 2023 press release Ground-Breaking Human Trial by Temple Therapeutics Solves 187-Year-Old Surgical Mystery of Eradicating Painful Adhesions https://lnkd.in/gjWZ9Xzd highlights the problem with adhesions. CNN #surgery #adhesions #complications https://lnkd.in/gjT8qXjh
Video: Lisa Marie Presley died from small bowel obstruction, autopsy says | CNN
cnn.com
-
BIOTECanada I am pleased to continue to serve as a Board Member amongst my esteemed colleagues and welcome our newest board members: Brigitte Nolet Najah Sampson Maha Katabi, PhD, CFA. The Canadian biotech ecosystem not only demonstrated its resilience during the pandemic but also exemplified its remarkable capabilities. At #BIO2023, Canada gathered an impressive cohort of over 800 delegates, ranking second only to the US. Presently, our 240+ members are passionately dedicated to developing therapeutics, diagnostics, and drug delivery systems, among a wide range of other essential tools, aimed at enhancing both the quality of life and the overall health span of individuals. Simultaneously, these innovations are not only contributing to cost containment within the healthcare system but also generating high-paying employment opportunities across Canada. It is an honour to be an integral part of the BIOTECanada team, and we take great pride in our collective efforts. #biotech #healthcare #venturecapital #lifesciences Gordon McCauley (He/Him) Roberto Bellini Paul Petrelli Oliver Technow Colleen Coxson Norma Biln Andrew (Andy) Haigh Alok Kanti, MBA, ICD.D Nancy Pei Tracey Ramsay Jamie Stiff Ali Tehrani Andrew Casey Janice Burke Pascale Lajoie Kostka Ron Boch Cate McCready Alexander Solomakha Shaely Williams, CAE Emily Meyers Aurelina Rodrigues https://lnkd.in/gvrMXdu7
BIOTECanada Announces Addition of Directors to Board of Directors - BIOTECanada
biotech.ca
-
If anyone has had #surgery you know what #adhesions are. An amazingly strong person. Had the pleasure of speaking to her and am glad her story is being shared! Temple Therapeutics recent phase 2 results is hope for millions who suffer like Ashely! #hysterectomy #csection #gynecology #fibroids #endometriosis https://lnkd.in/gXbCDveq
Ashley’s Journey
medium.com
-
How do investors and companies capture opportunity in #womenhealth? Believe Temple Therapeutics has an answer: Develop solutions to big problems, and comprising 51% of the population, there are many. #aacr2023 presentation on a prognostic marker for #ovariancancer, peer-reviewed publication on first pharmaceutical for post-operative adhesions, and many more upcoming milestones, the Company is looking to deliver on its mission of transforming #womens' lives. https://lnkd.in/g7kAfVmq
National Women's Health Week (NWHW) 2023
fda.gov